Souhaitez-vous accéder aux communiqués récents ?
Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.
-
EpiCept to Report Fourth Quarter and Full Year 2009 Operating and Financial Results on February 25, 2010 TARRYTOWN, N.Y.--(BUSINESS WIRE)--EpiCept Corporation (Nasdaq and Nasdaq OMX Stockholm: EPCT)...
-
EpiCept Establishes At-the-Market Public Stock Offering Program TARRYTOWN, N.Y.--(BUSINESS WIRE)-- Regulatory News: EpiCept Corporation (Nasdaq and Nasdaq OMX Stockholm: EPCT) announced today...
-
EpiCept Regains Nasdaq Compliance TARRYTOWN, N.Y.--(BUSINESS WIRE)-- Regulatory News: EpiCept Corporation (Nasdaq and Nasdaq OMX Stockholm Exchange: EPCT) today announced that Nasdaq notified the...
-
EpiCept to Present at 12th Annual BIO CEO & Investor Conference TARRYTOWN, N.Y.--(BUSINESS WIRE)--EpiCept Corporation (Nasdaq and OMX Nasdaq Stockholm Exchanges: EPCT) today announced that Jack...
-
EpiCept Receives Orphan Drug Designation for EpiCept™ NP-1 in U.S. TARRYTOWN, N.Y.--(BUSINESS WIRE)-- Regulatory News: EpiCept Corporation (Nasdaq and Nasdaq OMX Stockholm Exchange: EPCT)...
-
EpiCept Announces Ceplene® Included in Swedish AML Medical Guidelines First Official Endorsement by Medical Community TARRYTOWN, N.Y.--(BUSINESS WIRE)-- Regulatory News: EpiCept Corporation...
-
EpiCept Announces Reverse Split of Common Stock TARRYTOWN, N.Y.--(BUSINESS WIRE)-- Regulatory News: EpiCept Corporation (Nasdaq and Nasdaq OMX Stockholm Exchange: EPCT) (the “Company”) announced...
-
EpiCept Announces Executive Departure TARRYTOWN, N.Y.--(BUSINESS WIRE)-- Regulatory News: EpiCept Corporation (Nasdaq and OMX Nordic Exchange: EPCT) announced today the departure of Michael Chen,...
-
EpiCept Announces Commercial Licensing Agreement for Ceplene® with Meda in Europe and Pacific Rim Agreement Includes Upfront Payment, Milestones and Product Royalties TARRYTOWN, N.Y.--(BUSINESS...
-
EpiCept Announces Results of Special Meeting of Stockholders TARRYTOWN, N.Y.--(BUSINESS WIRE)-- Regulatory News: EpiCept Corporation (Nasdaq and OMX Nordic Exchange: EPCT) announced today...